Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Solid Tumor Trial in United States (CPO-100)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Dec 16, 2022

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Solid Tumor, Adult Trial in United States (JAB-3312, Binimetinib, Pembrolizumab)

Recruiting
  • Solid Tumor
  • NSCLC
  • Phoenix, Arizona
  • +14 more
Oct 26, 2022

Solid Tumor Trial in Seongnam-si (ASCA101)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +1 more
Oct 26, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

Suspended
  • Solid Tumor
  • NeoTCR-P1 adoptive cell therapy
  • +2 more
  • Duarte, California
  • +8 more
Aug 16, 2022

Solid Tumor Trial in United States (AO-176, AO-176 + Paclitaxel, AO-176 + Pembrolizumab)

Active, not recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Aug 3, 2022

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Solid Tumor Trial in Singapore, Spain, United States (BNT142)

Recruiting
  • Solid Tumor
  • BNT142
  • Los Angeles, California
  • +9 more
Jul 21, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

Solid Tumor Trial in United States (PRL3-zumab)

Recruiting
  • Solid Tumor
  • PRL3-zumab
  • Scottsdale, Arizona
  • +4 more
Apr 8, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (Minnelide™Capsules)

Recruiting
  • Advanced Cancer
  • +9 more
  • Birmingham, Alabama
  • +6 more
Apr 4, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (GNX102)

Recruiting
  • Solid Tumor
  • +3 more
  • Los Angeles, California
  • +5 more
Mar 7, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Solid Tumor, Lymphoma Trial in Los Angeles (DZ-002)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 2, 2022

Solid Tumor Trial in United States (STP707)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +3 more
Jan 27, 2022